Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up

Objectives To assess the feasibility considerations for a decentralised, one-stop-shop model of care implemented in Yangon, Myanmar.Setting Two primary care level clinics in urban Yangon, Myanmar.Design This is a feasibility study of a highly effective care model. Using Intervention Complexity Frame...

Full description

Saved in:
Bibliographic Details
Main Authors: Margaret Hellard, Alisa Pedrana, Hla Htay, Win Lei Yee, Khin Sanda Aung, Jessica Howell, Nwe Nwe, Philippa Easterbrook, Jessica Markby, Sonjelle Shilton, Bridget Louise Draper, Anna Bowring, Khin Pyone Kyi, Win Naing, Thin Mar Win
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/5/e059639.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850282776113184768
author Margaret Hellard
Alisa Pedrana
Hla Htay
Win Lei Yee
Khin Sanda Aung
Jessica Howell
Nwe Nwe
Philippa Easterbrook
Jessica Markby
Sonjelle Shilton
Bridget Louise Draper
Anna Bowring
Khin Pyone Kyi
Win Naing
Thin Mar Win
author_facet Margaret Hellard
Alisa Pedrana
Hla Htay
Win Lei Yee
Khin Sanda Aung
Jessica Howell
Nwe Nwe
Philippa Easterbrook
Jessica Markby
Sonjelle Shilton
Bridget Louise Draper
Anna Bowring
Khin Pyone Kyi
Win Naing
Thin Mar Win
author_sort Margaret Hellard
collection DOAJ
description Objectives To assess the feasibility considerations for a decentralised, one-stop-shop model of care implemented in Yangon, Myanmar.Setting Two primary care level clinics in urban Yangon, Myanmar.Design This is a feasibility study of a highly effective care model. Using Intervention Complexity Framework by Gericke et al, we collated and analysed programmatic data and evaluation data to outline key project implementation requirements and experiences.Participants Programmatic data were collected from clinical records, GeneXpert device test and maintenance reports, national guidelines, product and device instructions and site monitoring visit reports. Healthcare providers involved in delivering care model contributed interview data.Results The main feasibility considerations are appropriate storage for test kits and treatments (in response to temperature and humidity requirements), installation of a continuous stable electricity supply for the GeneXpert device, air-conditioning for the laboratory room hosting GeneXpert, access to a laboratory for pretreatment assessments and clear referral pathways for specialist consultation when required. Lessons from our project implementation experiences included the extensive time requirements for patient education, the importance of regular error monitoring and stock storage reviews and that flexible appointment scheduling and robust reminder system likely contributed to high retention in care.Conclusions Detailed documentation and dissemination of feasibility requirements and implementation considerations is vital to assist others to successfully implement a similar model of care elsewhere. We provide 10 recommendations for successful implementation.Trial registration number The trial was registered at ClinicalTrials.gov NCT03939013 on May 6, 2019. This manuscript presents post-results data on feasibility.
format Article
id doaj-art-270dafb44ee2428eac9aa81d5ee91c26
institution OA Journals
issn 2044-6055
language English
publishDate 2022-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-270dafb44ee2428eac9aa81d5ee91c262025-08-20T01:47:54ZengBMJ Publishing GroupBMJ Open2044-60552022-05-0112510.1136/bmjopen-2021-059639Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-upMargaret Hellard0Alisa Pedrana1Hla Htay2Win Lei Yee3Khin Sanda Aung4Jessica Howell5Nwe Nwe6Philippa Easterbrook7Jessica Markby8Sonjelle Shilton9Bridget Louise Draper10Anna Bowring11Khin Pyone Kyi12Win Naing13Thin Mar Win14School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, AustraliaBurnet Institute, Melbourne, Victoria, Australia3 Disease Elimination, Burnet Institute Myanmar, Yangon, Myanmar3 Disease Elimination, Burnet Institute Myanmar, Yangon, Myanmar8 National Hepatitis Control Program, Department of Public Health, Ministry of Health and Sports, Yangon, Myanmar10 Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia4 FIND, Geneva, SwitzerlandWorld Health Organization, Geneva, SwitzerlandFIND, Geneva, SwitzerlandFIND, Geneva, Switzerland2 School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, AustraliaBurnet Institute, Melbourne, Victoria, Australia5 Myanmar Liver Foundation, Yangon, Myanmar5 Myanmar Liver Foundation, Yangon, MyanmarMyanmar Country Program, Burnet Institute, Yangon, MyanmarObjectives To assess the feasibility considerations for a decentralised, one-stop-shop model of care implemented in Yangon, Myanmar.Setting Two primary care level clinics in urban Yangon, Myanmar.Design This is a feasibility study of a highly effective care model. Using Intervention Complexity Framework by Gericke et al, we collated and analysed programmatic data and evaluation data to outline key project implementation requirements and experiences.Participants Programmatic data were collected from clinical records, GeneXpert device test and maintenance reports, national guidelines, product and device instructions and site monitoring visit reports. Healthcare providers involved in delivering care model contributed interview data.Results The main feasibility considerations are appropriate storage for test kits and treatments (in response to temperature and humidity requirements), installation of a continuous stable electricity supply for the GeneXpert device, air-conditioning for the laboratory room hosting GeneXpert, access to a laboratory for pretreatment assessments and clear referral pathways for specialist consultation when required. Lessons from our project implementation experiences included the extensive time requirements for patient education, the importance of regular error monitoring and stock storage reviews and that flexible appointment scheduling and robust reminder system likely contributed to high retention in care.Conclusions Detailed documentation and dissemination of feasibility requirements and implementation considerations is vital to assist others to successfully implement a similar model of care elsewhere. We provide 10 recommendations for successful implementation.Trial registration number The trial was registered at ClinicalTrials.gov NCT03939013 on May 6, 2019. This manuscript presents post-results data on feasibility.https://bmjopen.bmj.com/content/12/5/e059639.full
spellingShingle Margaret Hellard
Alisa Pedrana
Hla Htay
Win Lei Yee
Khin Sanda Aung
Jessica Howell
Nwe Nwe
Philippa Easterbrook
Jessica Markby
Sonjelle Shilton
Bridget Louise Draper
Anna Bowring
Khin Pyone Kyi
Win Naing
Thin Mar Win
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
BMJ Open
title Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
title_full Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
title_fullStr Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
title_full_unstemmed Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
title_short Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
title_sort feasibility of decentralised task shifted hepatitis c testing and treatment services in urban myanmar implications for scale up
url https://bmjopen.bmj.com/content/12/5/e059639.full
work_keys_str_mv AT margarethellard feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT alisapedrana feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT hlahtay feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT winleiyee feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT khinsandaaung feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT jessicahowell feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT nwenwe feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT philippaeasterbrook feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT jessicamarkby feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT sonjelleshilton feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT bridgetlouisedraper feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT annabowring feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT khinpyonekyi feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT winnaing feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup
AT thinmarwin feasibilityofdecentralisedtaskshiftedhepatitisctestingandtreatmentservicesinurbanmyanmarimplicationsforscaleup